Plain-English translation of NCT05497115 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a program called the Trauma Resilience and Recovery Program (TRRP) designed to help people who have survived traumatic injuries. The program uses a step-by-step approach: starting with bedside education and screening in the hospital, followed by text message support, a check-in for depression and PTSD about a month after injury, and help connecting to mental health services if needed. The study will compare this new program to standard care over one year to see if it improves recovery and makes mental health care easier to access.
Many trauma survivors struggle with depression and post-traumatic stress, but they often don't get the mental health support they need. This trial exists to test whether a coordinated, step-by-step program can catch people at risk earlier, keep them engaged during recovery, and help them connect to real mental health services.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the new Trauma Resilience and Recovery Program or standard mental health education and referral information. With the new program, you would receive in-hospital education and screening, text message support over time, a phone or chat screening about a month after injury, and connection to mental health services if needed. You will have follow-up visits or calls at 3, 6, and 12 months after starting the program to check on your recovery and well-being. Some participants will also be asked to share their experiences in interviews.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States
Sponsor
Medical University of South Carolina
Collaborators
George Washington University, Agency for Healthcare Research and Quality (AHRQ)
Enrollment target
~350 participants
Started
November 2022
Primary completion
March 2027
Age range
16 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gabriela Becerra, BS
Medical University of South Carolina
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.